FutureTox III: Transforming 21st Century Science into Risk Assessment and Regulatory Decision-Making will be held November 19–20, 2015, in Arlington, Virginia.
In the effort to prevent neural tube defects (NTD), the World Health Organization (WHO) has released guidelines for optimal red blood cell (RBC) folate concentrations in women of reproductive age, based on the best currently available evidence.
On June 8 and 9, 2015, the Risk Communication Advisory Committee will discuss approaches to communicating information about fetal effects in product labeling for methadone or buprenorphine maintenance therapy for opioid addiction, and about the maternal benefits and risks of treatment.
